DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 13,940
-210 (-1.48%)
At close: Apr 9, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 245.23 billion as of April 10, 2026. Its market cap has decreased by -14.63% in one year.
Market Cap
245.23B
Enterprise Value
340.98B
Revenue
143.06B
Ranking
n/a
PE Ratio
148.94
Stock Price
13,940.00
Market Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 245.23B, an increase of 1,465.17%. That is a compound annual growth rate of 13.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 245.23B | -19.68% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 453.97B |
| CellBion | 391.36B |
| NOVAREX | 240.93B |
| GREEN CROSS WellBeing | 234.24B |
| High Tech Pharm | 207.67B |
| OPTUS Pharmaceutical | 160.05B |
| Vivozon Pharmaceutical | 148.40B |
| Kyung Dong Pharmaceutical | 144.41B |